TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

Sapien 3 Ultra THV outperforms its predecessor, reducing PVL after TAVR procedures

The risk of all-cause mortality, stroke, major bleeding events or permanent pacemaker implantation was similar between the two valves.

Thumbnail

Adjusting implantation technique during TAVR reduces risk of permanent pacemakers

Researchers emphasized that permanent pacemakers are “one of the most feared complications" associated with TAVR. 

Thumbnail

Hydra THV associated with promising TAVR outcomes after 1 year

Researchers reported "significant improvements" in patients after one year. 

Self-expanding TAVR system gains approval for high-risk patients in China

The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.

Thumbnail

AI improves detection of severe CAD in stress echocardiograms

Advanced algorithms can lead to significant improvements in agreement among specialists, researchers found. 

Thumbnail

Prosthetic-patient mismatch after TAVR much less likely among Asian patients

Patient outcomes, it seems, are not significantly impacted by this trend. 

Thumbnail

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization. 

Thumbnail

Certain patients with chronic kidney disease face a higher risk of death after TAVR

No such trend was reported among patients with end-stage kidney disease.

Displaying 297 - 304 of 417

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.